Cancer in IBD: Inflammation, Surveillance, Management

Co-Moderator(s)

• 

  Emina Huang, MD, MBA

  Professor of Surgery, Vice-Chair for Research Department of Surgery
  University of Texas Southwestern
  University of Texas
  Dallas, TX, United States

  All of the relevant financial relationships listed below have been mitigated.
  This individual has no financial relationships with ineligible companies.
• 

  Vitaliy Poylin, MD, MBA

  Director, Section of Colon and Rectal Surgery
  Northwestern University Feinberg School of Medicine
  Northwestern University Feinberg School of Medicine
  Chicago, IL, United States

  All of the relevant financial relationships listed below have been mitigated.
  This individual has no financial relationships with ineligible companies.

CME: .75 hours
Self-

Assessment: .75 hours

The etiology, prevalence, surveillance strategies and management of cancer in inflammatory bowel disease is undergoing evolution. This symposia will provide the most current understanding, with evidence-based guidance and structure regarding surveillance and surgical approaches

Presentations:

• 1:20 PM - 1:23 PM ET

  Introduction
• 1:25 PM - 1:37 PM ET

  Pathogenesis and Etiology of Colitis-associated Cancer in the Era of Current Medical Treatments
  

  Faculty: Nimalan Arjun Jeganathan, MD – Penn State College of Medicine
• 1:39 PM - 1:51 PM ET

  National and Society Guidelines to Surveillance for Cancer in Colitis
  

  Faculty: David M. Schwartzberg, MD, FACS, FASCRS – Northwell Health, Center for Advanced IBD Care
• 1:52 PM - 2:05 PM ET

  Surgical Management of Dysplasia and Colitis-associated Cancer: Real-world Experience
  

  Faculty: Jean H. Ashburn, MD – Atrium Health Wake Forest Baptist
• 2:06 PM - 2:10 PM ET

  Questions and Polling